Shanghai
China
COVID-19; SARS-CoV-2; lymphocyte subsets; cytokine storm; matrix analysis
Small cell lung cancers (SCLCs); Whole-exome sequencing (WES); Bioinformatics; Tumor mutation burden (TMB); Somatic copy number alterations (SCNAs); De novo signature